SHIKIAR ASSET MANAGEMENT INC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHIKIAR ASSET MANAGEMENT INC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50
-35.9%
15,7500.0%0.02%
-32.0%
Q2 2023$78
-32.2%
15,750
-32.3%
0.02%
-39.0%
Q1 2023$115
-100.0%
23,2500.0%0.04%
-59.4%
Q3 2022$251,000
-5.3%
23,2500.0%0.10%
-1.0%
Q2 2022$265,000
+25.0%
23,2500.0%0.10%
+70.0%
Q1 2022$212,000
-38.9%
23,2500.0%0.06%
-31.8%
Q4 2021$347,000
-45.5%
23,250
-6.2%
0.09%
-50.8%
Q3 2021$637,000
-12.4%
24,785
-11.1%
0.18%
-12.7%
Q2 2021$727,000
-16.9%
27,885
+12.5%
0.20%
-30.5%
Q1 2021$875,000
-1.8%
24,785
-29.8%
0.30%
-8.1%
Q4 2020$891,000
-21.8%
35,285
+16.7%
0.32%
-26.7%
Q3 2020$1,140,000
-12.2%
30,225
-0.3%
0.44%
-26.0%
Q2 2020$1,299,000
+135.8%
30,325
+7.1%
0.59%
+60.0%
Q1 2020$551,000
-40.5%
28,325
-20.5%
0.37%
+20.5%
Q4 2019$926,000
-2.9%
35,645
+1.9%
0.31%
-18.6%
Q3 2019$954,000
-18.1%
34,995
-19.4%
0.38%
-17.3%
Q2 2019$1,165,000
-22.2%
43,395
-16.2%
0.46%
-27.3%
Q1 2019$1,497,000
+41.8%
51,785
+32.1%
0.63%
+13.6%
Q4 2018$1,056,00039,2000.55%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders